Advocates cheer OTC approval for Narcan, but questions remain about price, insurance - The Boston Globe

Posted on AllSides March 29th, 2023
From The Left

But questions remain about how the decision will affect access in states such as Massachusetts where naloxone is already widely available behind the pharmacy counter, for little or no cost to consumers. Over-the-counter drugs are not usually covered by insurance, and the manufacturer has not announced a price. The FDA said its decision will allow the drug to be sold without a prescription “directly to consumers in places such as drug stores, convenience stores, grocery stores, and gas stations, as well as online.” The US Food and Drug Administration on...

Read full story
Some content from this outlet may be limited or behind a paywall.

The Boston Globe

AllSides Media Bias Rating: Left
AllSides Media Bias Rating: Left
See full bias rating for The Boston Globe
Learn about media bias

More News about Politics from the Left, Center and Right

From the Left

From the Center

From the Right